Search Results 111-120 of 8643 for Raloxifene

1. Cemiplimab-rwlc (intravenous route) - Mayo Clinic

   Cemiplimab-rwlc injection is used to treat a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread (metastatic) or cannot be cured ...

2. Denosumab Stimulated Parathyroid Scan Pilot Study in Persistent or Recurrent Primary Hyperparathyroidism - Mayo Clinic

   Use of medications that may alter serum calcium levels such as cinacalcet, estrogen therapy, raloxifene, teriparatide, hydrochlorothiazide, lithium, or ...

3. A Study of the Efficacy of Lorcaserin for Weight Loss in Overweight Peri- and Postmenopausal Women - Mayo Clinic

   Progestogens; Tamoxifen, raloxifene and aromatase inhibitors are allowed, but patient must have been on a constant dose for at least 28 days and must not be ...

4. A Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of RO7248824 In Participants With Angelman Syndrome - Mayo Clinic

   The primary objective of this study is to investigate the safety and tolerability of RO7248824 in participants with Angelman Syndrome (AS) aged 1-12 years.

5. Ixazomib Citrate, Lenalidomide, Dexamethasone, And Daratumumab In Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Monoclonal antibodies, such as daratumumab, may block cancer growth in different ways by targeting certain cells. Giving ixazomib citrate, lenalidomide, ...

6. Secukinumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Secukinumab injection is also used to treat active ankylosing spondylitis, non-radiographic axial spondyloarthritis (a type of arthritis in the spine) with ...

7. BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors In Patients With Advanced Solid Tumors, Phase I Studies With Expansion Cohorts In Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) And Pancreatic Adenocarcinoma (PDA) - Mayo Clinic

   BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors In Patients With Advanced Solid Tumors, Phase I Studies With Expansion Cohorts In Small Cell Lung Carcinoma ( ...

8. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

   ... raloxifene). Adjuvant hormonal agents (e.g., tamoxifen, aromatase inhibitors) allowed after completion of chemotherapy as part of treatment for breast cancer.

9. BRCA gene test for breast and ovarian cancer risk - Mayo Clinic

   For breast cancer risk, options may include medicines such as tamoxifen or raloxifene. These medicines can lower breast cancer risk in women at higher risk ...

10. MBI Response ToTam - Mayo Clinic

    Selective estrogen receptor modulators (tamoxifen, raloxifene, or toremifene); Aromatase inhibitors (anastrazole, letrozole, or exemestane); GnRH analogs ...